SCHEMBL5862066

SCHEMBL5862066

O=C=Nc1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.50
▸ TSHR P16473 1/20 0.50
▸ TDP1 Q9NUW8 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ BCL2L1 Q07817 1/20 0.40
▸ BAD Q92934 1/20 0.40
▸ TRPA1 O75762 1/20 0.39
▸ CYP1A2 P05177 1/20 0.37
▸ SLC22A2 O15244 1/20 0.37
▸ SLC22A1 O15245 1/20 0.37
▸ SLC22A3 O75751 1/20 0.37
▸ PLAU P00749 1/20 0.37
▸ NOS3 P29474 2/20 0.35
▸ NOS1 P29475 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ PYCR1 P32322 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93163 0.93 CYP3A4 (0.56) CYP3A4TSHRTDP1MAPK1TRPA1
SCHEMBL241534 0.88 CYP3A4 (0.61) CYP3A4TSHRTDP1MAPK1TRPA1
SCHEMBL23721668 0.88 CYP3A4 (0.61) CYP3A4TSHRTDP1MAPK1TRPA1
Water SCHEMBL3898007 0.85 CYP3A4 (0.58) CYP3A4TSHRTDP1MAPK1TRPA1
Hydrogen Sulfide SCHEMBL3894665 0.85 CYP3A4 (0.58) CYP3A4TSHRTDP1MAPK1TRPA1
Fluorobenzene SCHEMBL2828466 0.84 CYP3A4 (0.48) CYP3A4TSHRTDP1MAPK1TRPA1
SCHEMBL8093595 0.83 TDP1 (0.48) CYP3A4TSHRTDP1MAPK1TRPA1
SCHEMBL7523448 0.83 CYP3A4 (0.47) CYP3A4TSHRTDP1MAPK1TRPA1
SCHEMBL2114610 0.81 CYP3A4 (0.54) CYP3A4TSHRTDP1MAPK1TRPA1
SCHEMBL29849714 0.81 AGXT (0.40) CYP3A4TDP1MAPK1BCL2L1BAD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7049307-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-05-23 — — US disclosed
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-08-25 — — US disclosed
US-20050137187-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137187-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R CYP3A4 3472/4885TSHR 12/4885TDP1 709/4885
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R CYP3A4 3472/4885TSHR 12/4885TDP1 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback